Synergic anticancer effects of morin hydrate and sorafenib delivered via polymeric iron oxide nanoparticles for the treatment of triple-negative breast cancer.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.